Please login to the form below
Healthcare Glossary
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W |
Side-effects
The negative effects a drug or treatment may have on a patient. Common side-effects include headache, nausea and skin irritation. Drugs are evaluated for both long- and short-term side-effects, with drug manufacturers required to list all known side effects of a product on its packaging.
See also:
Clinical trial
Adverse reaction
Packaging
Related terms
Expanded access, Adverse reaction, Brief summary, Toxicity, Adherence, Clinical trial, Investigational new drug (IND), Commission on Human Medicines (CHM), Fair balance, Compassionate use, Drug-drug interaction, Food And Drug Administration (FDA), Contraindication, Phase I trials, Diagnostic trials,
COVID-19 Updates and Daily News
Featured jobs
- Medical Writer, MRNA/ Covid 19, Medical Communications, UK
-
Highly competitive salary
-
Head of Copy
-
£ competitive
-
Account Manager
-
Competitive salary with bonus and benefits
- Client Services Director, MRNA/ Covid 19, Medical Communications...
-
Highly competitive salary
- Editorial Team Leader, Medical Communications, Oxford
-
Competitive Salary
- Graduate Business Analyst, Healthcare Communications – Pharma/ S...
-
Highly competitive salary
- Merck and Eisai share crucial phase 3 trial results for advanced endometrial carcinoma treatment
- AstraZeneca’s Imfinzi and tremelimumab show unprecedented survival rate in liver cancer patients
- Sanofi and Regeneron’s Dupixent receives second positive phase 3 trial results
- GSK appoint Tony Wood as chief scientific officer
- Almirall and IRB Barcelona announce new research collaboration
- PM announces plans to lift England’s COVID-19 restrictions
- Let's explore new frontiers
- FDA grants priority review for Roche’s Evrysdi for spinal muscular atrophy in babies
- Ipsen’s Sohonos approved by Health Canada
- Personalised medicine: driving a need for greater diversity in clinical trials
- Live Webinar: Protecting Ownership of Technological & Pharmaceutical Innovation
- Lucid Group Welcomes a New Cohort of Graduates into its Futures Academy
- Why pharma must get smart in its approach to customer engagement
- Pfizer lifts 2021 guidance as sales of its BioNTech-partnered vaccine continue to climb
- Sanofi and Exscientia agree on a deal worth up to $5.2bn for AI-driven therapies
- Six factors that drive a multiple sclerosis patient's choice of disease-modifying therapy
- Amgen’s Lumykras receives conditional marketing authorisation from EC
- AstraZeneca’s Imfinzi and tremelimumab show unprecedented survival rate in liver cancer patients
